Michael M - Search Results

1

Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.

Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Thang SP, et al. Among authors: michael m. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):262-277. doi: 10.1007/s00259-017-3821-2. Epub 2017 Sep 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 28894897

2

FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burden.

MacManus MR, Hicks R, Fisher R, Rischin D, Michael M, Wirth A, Ball DL. MacManus MR, et al. Among authors: michael m. Acta Oncol. 2003;42(1):48-54. doi: 10.1080/0891060310002230. Acta Oncol. 2003. PMID: 12665331

3

Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience.

Blum R, MacManus MP, Rischin D, Michael M, Ball D, Hicks RJ. Blum R, et al. Among authors: michael m. Am J Clin Oncol. 2004 Apr;27(2):164-71. doi: 10.1097/01.coc.0000054889.58718.6f. Am J Clin Oncol. 2004. PMID: 15057156

4

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J, Rischin D. Loi S, et al. Among authors: michael m. Br J Cancer. 2005 Feb 28;92(4):655-61. doi: 10.1038/sj.bjc.6602413. Br J Cancer. 2005. PMID: 15700033 Free PMC article. Clinical Trial.

5

FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.

Duong CP, Hicks RJ, Weih L, Drummond E, Leong T, Michael M, Thomas RJ. Duong CP, et al. Among authors: michael m. Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):770-8. doi: 10.1007/s00259-005-0040-z. Epub 2006 Mar 21. Eur J Nucl Med Mol Imaging. 2006. PMID: 16550384 Clinical Trial.

6

177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide.

Hubble D, Kong G, Michael M, Johnson V, Ramdave S, Hicks RJ. Hubble D, et al. Among authors: michael m. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1869-75. doi: 10.1007/s00259-010-1483-4. Epub 2010 May 6. Eur J Nucl Med Mol Imaging. 2010. PMID: 20445977

7

Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome.

Yeung JM, Kalff V, Hicks RJ, Drummond E, Link E, Taouk Y, Michael M, Ngan S, Lynch AC, Heriot AG. Yeung JM, et al. Among authors: michael m. Dis Colon Rectum. 2011 May;54(5):518-25. doi: 10.1007/DCR.0b013e31820b36f0. Dis Colon Rectum. 2011. PMID: 21471751

8

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.

Day FL, Link E, Ngan S, Leong T, Moodie K, Lynch C, Michael M, Winton Ed, Hogg A, Hicks RJ, Heriot A. Day FL, et al. Among authors: michael m. Br J Cancer. 2011 Aug 9;105(4):498-504. doi: 10.1038/bjc.2011.274. Epub 2011 Jul 26. Br J Cancer. 2011. PMID: 21792197 Free PMC article.

9

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).

Kong G, Thompson M, Collins M, Herschtal A, Hofman MS, Johnston V, Eu P, Michael M, Hicks RJ. Kong G, et al. Among authors: michael m. Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1831-44. doi: 10.1007/s00259-014-2788-5. Epub 2014 May 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24844348 Free PMC article.

10

Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours.

Kashyap R, Hofman MS, Michael M, Kong G, Akhurst T, Eu P, Zannino D, Hicks RJ. Kashyap R, et al. Among authors: michael m. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):176-85. doi: 10.1007/s00259-014-2906-4. Epub 2014 Sep 11. Eur J Nucl Med Mol Imaging. 2015. PMID: 25209134 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,032 results

Search Page

Filters